PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET ANALYSIS

Market Challenges And Opportunities

Global Peripherally Inserted Central Catheters Market: Restraints

Recalls of products

The recalls of peripherally inserted central catheters is expected to hamper the global peripherally inserted central catheters market growth. For instance, on December 16, 2022, a U.S. FDA announced Teleflex Incorporated, a U.S.-based global provider of medical technologies and Arrow International, Inc., a U.S.-based medical equipment & devices manufacturer, recalling both the Arrow MAC Two-Lumen Central Venous Access Kit and the Arrow Pressure Injectable Arrowg+ard Blue Plus Three-Lumen Central Venous Catheter Kit. The reason for the recall is the risk of a cross-lumen leak caused by inadequate connections between the top and bottom housings of the Micro Clave Clear Connectors included in the kits. Device may reportedly cause bleeding, fluid leakage, delayed treatment, infection, air embolism, death or other serious injuries in patients treated with these device, however, no injuries or deaths have been reported.

To counterbalance this restraint, more research & development activities should be carried out to avoid recalls.

Lack of awareness of central venous catheters

In emerging economies, lack of awareness of central venous catheters is expected to hamper the global peripherally inserted central catheters market growth. For instance, according to an article published in the Journal of Hospital Medicine on February 25, 2020, 375 patient records were accessed and the providers interviewed regarding awareness of presence of a PICC in its patients. Results demonstrated that many physicians are not aware of whether the patient has a central line. Such unawareness may lead to unnecessary complications which can restrain growth of market.

To counterbalance this restrain, more training to caregiver and physicians should be given.

Global Peripherally Inserted Central Catheters Market– Drivers

Increasing prevalence of infectious disease

Increasing prevalence of infectious disease is expected to drive the global peripherally inserted central catheters market growth over the forecast period. For instance, according to the data shared by the Centers for Disease Control and Prevention, on January 25, 2023, worldwide burden of infectious diseases has increased from 37.9% to 61.8%. High-income nations like Italy, Japan, Singapore, and Canada typically account for more than 80 % of disease burden. In U.S. in 2020, the number of new cases of tuberculosis (8,916), salmonella (58,371), Lyme disease (34,945), and meningococcal disease (371) were rising constantly. Such infectious diseases require antibiotics therapy that uses peripherally inserted central catheters (PICC). This ultimately shows positive impact on global peripherally inserted central catheters market.

Increasing Launches of New Technologies & Products

Increasing launch of new products to make the working process of catheters more efficient is expected to drive the global peripherally inserted central catheters market growth. For instance, on February 2, 2022, Zeus Company Inc., a Singapore-based precision polymer manufacturer announced that it has added Polytetrafluoroethylene (PTFE) Sub-Lite-Wall multi-lumen tubing to its product portfolio. Zeus Company Inc.’s PTFE Sub-Lite-Wall multi-lumens have average max wall thicknesses ranging from 0.002" to 0.005" (0.051 mm to 0.127 mm). In addition to ultra-thin walls, the new product features high structural integrity, improved planarity, high lubricity, and excellent dielectric strength. It is biocompatible (certified United States Pharmacopeia (USP) Class VI) and has a working temperature of 260 °C (500 °F).